You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

IPS Launches CarTon™ – the End-to-End Compliance Solution

Oct 29, 2019


IPS Launches CarTon™ – the End-to-End Compliance Solution

Oct 29, 2019

- The Future of Operational Readiness for Cell and Gene Therapy -

Blue Bell, Pennsylvania, October 29, 2019 – IPS-Integrated Project Services, LLC, a leading provider of consulting, architecture, engineering, construction management, and CGMP compliance services, announces the launch of CarTon, an end-to-end integrated operational readiness compliance solution for cell and gene therapy facilities.

Where speed to market is critical for saving lives, CarTon simplifies the complex maze of activities required to bring a new cell and gene therapy facility to a fully operational state. This end-to-end compliance solution contains the entire process life cycle including facility and process requirements, standardized protocol templates, QMS/SOP development, training, and other necessities for CGMP manufacturing in a global market.

IPS has a depth of subject matter expertise and is uniquely positioned to support the cell and gene therapy industry. CarTon compliments the robust offering of services including compliant facility design, engineering, traditional and modular construction, and all aspects of commissioning, qualification, and validation. With CarTon, cell and gene therapy companies achieve Quality by Design CGMP facility, compliance through commissioning, qualification & validation, and operational readiness - quality management systems documents and services all under one company.

The combination of IPS’ core services provides cell and gene therapy companies a complete turn-key solution to get their medical brilliance to awaiting patients. With their modular facility platform, iCON, the IPS and G-CON Manufacturing collaboration, providing the most flexible and rapidly deployable facility to meet the modular and mobile demands of the industry, CarTon takes the iCON solution one-step further to a fully operational, integrated solution or as an independent operational readiness solution on any project.

“With hundreds of cell and gene therapies in clinical trials, we are excited to launch this new, all in one box, end-to-end compliance solution to support operational readiness for cell and gene companies,” stated Vince Cebular, SVP, Compliance. “We created CarTon because time is lives.”

To learn more, visit our webpage for CarTon.

About IPS-Integrated Project Services, LLC
IPS is a global leader in developing innovative business solutions for the biotechnology and pharmaceutical industries. Through operational expertise and industry-leading knowledge, skill and passion, IPS provides consulting, architecture, engineering, construction management, and compliance services that allow clients to create and manufacture life-impacting products around the world. Headquartered in Blue Bell, Pennsylvania-USA, IPS is one of the fastest-growing companies servicing the life sciences industry with nearly 1,400 professionals in the United States, Canada, Brazil, the United Kingdom, Ireland, Switzerland, Singapore, China, and India. For more information about IPS, please visit

Dept. of Marketing and Communications  +1.484.344.9234

Related Experts


Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.


We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.